US President Joe Biden has commuted the death sentences of 37 prisoners awaiting execution on federal death row, in one of ...

GenAI is generative, focusing on creating new content based on learned data, whether it’s text, images or molecular ...

The combined group is expected to have around 33,000 employees, with a reduction in headcount of 5 to 7 per cent, Aviva said ... Big share price moves in Europe today include Danish drugmaker Novo ...

CEO Philip Daffas has a simple vision for the company’s digital pain-assessment tool: “to be the next Australian technology ...

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

Wanderlust Magazine has just released its highly anticipated 2025 Good to Go List, spotlighting destinations that offer ...

Novo Holdings A/S said Monday that it has completed its $16.5 billion all-cash acquisition of Catalent (CTLT, Financials). Catalent will be privately held by Danish life sciences investment ...

the controlling shareholder of Novo Nordisk (NOVOb.CO), opens new tab, on Wednesday sealed its $16.5 billion deal for Catalent (CTLT.N), opens new tab, as the Danish drugmaker looks to boost ...

(Reuters) - All regulatory closing conditions related to Novo Holdings' $16.5 billion acquisition of U.S. contract drug maker Catalent had been fulfilled, the companies said on Saturday ...

Insilico Medicine (‘Insilico’), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and ...

Dec 14 (Reuters) - All regulatory closing conditions related to Novo Holdings' $16.5 billion acquisition of U.S. contract drug maker Catalent (CTLT.N), opens new tab had been fulfilled ...

Following the Danish drugmaker's results announcement, Novo's share price fell by 19.5 per cent on Friday to its lowest since August 2023. The drugmaker stated that the data from the Phase III ...